Overall survival analysis indicated the lack of significant differences in the protein expression of IDO1, IDO2, TDO2, and IL4I1 in DLBCL and NK/TCL groups using IHC analysis (Figure 3A,B). This evidence concerns the gene IDO2 and diffuse large B-cell lymphoma.